pharmaceutical investing BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT
pharmaceutical investing BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT
biotech investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
biotech investing BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+
biotech investing BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer
biotech investing BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
Prismo Metals Assay Results at Silver King Show Highs of 1.73% copper, 30 ppm molybdenum, 1,362 g/t silver, 4.1% lead, and 1.3 g/t gold
